IndraLab
Statements
YOD1 activates Neoplasm Metastasis. 7 / 7
|
7
reach
"Thus, DEX activates the miR-143-3p/epidermal growth factor receptor (EGFR) pathway substrate 8 axis, increases miR-493-5p, which targets RASL11B implicated in cancer development, decreases the expression of miR-1307, upregulates miR-185, which inactivates the Sry (sex determining region Y)-box 9 (SOX9)/Wnt/B-catenin pathway and miR-520a-3p that targets the metastases-inducing gene Yod1 coding for the deubiquitinating enzyme YOD1."